Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen, a biotechnology company that discovers, develops, manufactures and delivers human therapeutics, reported total revenues of $3.96m for the second quarter ended 30 June 2011, an increase of 4%, compared to $3.8m for the same period in 2010.
Subscribe to our email newsletter
Amgen‘s adjusted net income was $1.28m, compared to $1.33m for the same period in the prior year.
The company has posted adjusted operating income of $1.47m for the second quarter ended 30 June 2011, compared to $1.65m for the same period in 2010.
Adjusted earnings per share (EPS) were $1.37 for the second quarter of 2011, a decrease of 1%, compared to $1.38 for the second quarter of 2010.
Amgen chairman and CEO Kevin Sharer said their products recorded 8% growth during the quarter.